DCF — HONORHEALTH SCOTTSDALE SHEA MED CTR
Enterprise Value: $-236.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-236.0M
Enterprise Value
$-90.8M
PV of Cash Flows
$-145.2M
PV of Terminal Value
$-233.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $627.6M | $-5.9M | -1.0% | $-32.5M | $-29.5M |
| Year 2 | $646.4M | $0.4M | 0.0% | $-27.0M | $-22.3M |
| Year 3 | $665.8M | $7.1M | 1.0% | $-21.1M | $-15.9M |
| Year 4 | $685.8M | $10.7M | 2.0% | $-18.3M | $-12.5M |
| Year 5 | $706.4M | $12.8M | 2.0% | $-17.1M | $-10.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-236.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$609.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.014391289671039118
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5